3,4-dihydroxybenzohydroxamic acid has been researched along with Hypersensitivity in 1 studies
Hypersensitivity: Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McLeod, JJA | 1 |
| Caslin, HL | 1 |
| Spence, AJ | 1 |
| Kolawole, EM | 1 |
| Qayum, AA | 1 |
| Paranjape, A | 1 |
| Taruselli, M | 1 |
| Haque, TT | 1 |
| Kiwanuka, KN | 1 |
| Elford, HL | 1 |
| Ryan, JJ | 1 |
1 other study available for 3,4-dihydroxybenzohydroxamic acid and Hypersensitivity
| Article | Year |
|---|---|
Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IgE-mediated mast cell activation through attenuation of NFκB and AP-1 transcription.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antioxidants; Bone Marrow Cells; Catalase; Cell D | 2017 |